Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0360220160570040582
Journal of the Korean Ophthalmological Society
2016 Volume.57 No. 4 p.582 ~ p.587
Influence of Intravitreal Bevacizumab Injection on Formation of Collateral Vessels in Branch Retinal Vein Occlusion
¼Õ¿µ¿ì:Son Yeong Woo
À̽¿ì:Lee Seung-Woo
Abstract
Purpose: To evaluate the influence of retinal collateral vessels in eyes with macular edema secondary to branch retinal vein occlusion (BRVO) treated with intravitreal bevacizumab (IVB).

Methods: We reviewed the medical records of patients with BRVO who were followed up for 12 months. To compare formations of collateral vessels, the patients were divided into 2 groups. The treatment group included 20 patients (20 eyes) treated with IVB, and the control group included 41 patients (41 eyes) without treatment.

Results: In the treatment group, the mean age was 58.4 ¡¾ 9.5 years. The average number of IVB injections performed during the 12 months was 4.5 ¡¾ 2.5 (range 2 to 8). After 12 months from diagnosis, 13 eyes (65%) presented with collateral vessels. In the control group, the mean age was 60.6 ¡¾ 9.3 years and 28 eyes (68.3%) presented with collateral vessel after 12 months. There was no difference in incidence of collateral vessel formation between the treatment group and the control group (p = 0.574).

Conclusions: IVB does not influence the formation of retinal collateralization in eyes treated for macular edema secondary to BRVO.
KEYWORD
Bevacizumab, Collateral Vessels, Macular Edema, Retinal Vein Occlusion
FullTexts / Linksout information
 
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø